Seskviterpeny v protinádorové terapii

Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Mgr. Martin Ambrož Supervisor: Prof. RNDr. Lenka Skálová, Ph.D. Title of Doctoral Thesis: Sesquiterpenes in cancer therapy. Chemotherapy is an important part of treatment of cancer. Currently, the...

Full description

Bibliographic Details
Main Author: Ambrož, Martin
Other Authors: Skálová, Lenka
Format: Doctoral Thesis
Language:Czech
Published: 2017
Online Access:http://www.nusl.cz/ntk/nusl-370949
id ndltd-nusl.cz-oai-invenio.nusl.cz-370949
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3709492018-11-16T04:18:06Z Seskviterpeny v protinádorové terapii Sesquiterpenes in cancer therapy Ambrož, Martin Skálová, Lenka Hodek, Petr Souček, Pavel Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Mgr. Martin Ambrož Supervisor: Prof. RNDr. Lenka Skálová, Ph.D. Title of Doctoral Thesis: Sesquiterpenes in cancer therapy. Chemotherapy is an important part of treatment of cancer. Currently, the use of several anticancer drugs in combination seem to be more advantageous. This combination therapy prevents drug resistance development and make it possible to lower the doses of single drugs, which prevents the side effects in non-cancerous tissues. Large pool of potential drugs for combination therapy can be found among natural compounds, for example among sesquiterpenes. Our project was designed to evaluate the effect of Myrica rubra essential oil (MEO) and selected sesquiterpenes in combination cancer therapy. We focused on the potential ability of MEO and sesquiterpenes to increase the antiproliferative efficacy of classical cytostatics (doxorubicin, oxaliplatin, 5-fluorouracil). In addition, we also studied the possible interaction of sesquiterpenes with other drugs in combination therapy, which could be caused by sesquiterpene-mediated modulation of drug-metabolizing enzymes. For these purposes, a panel of various cell lines (both cancerous and non-cancerous) and primary culture of hepatocytes... 2017 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-370949 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Mgr. Martin Ambrož Supervisor: Prof. RNDr. Lenka Skálová, Ph.D. Title of Doctoral Thesis: Sesquiterpenes in cancer therapy. Chemotherapy is an important part of treatment of cancer. Currently, the use of several anticancer drugs in combination seem to be more advantageous. This combination therapy prevents drug resistance development and make it possible to lower the doses of single drugs, which prevents the side effects in non-cancerous tissues. Large pool of potential drugs for combination therapy can be found among natural compounds, for example among sesquiterpenes. Our project was designed to evaluate the effect of Myrica rubra essential oil (MEO) and selected sesquiterpenes in combination cancer therapy. We focused on the potential ability of MEO and sesquiterpenes to increase the antiproliferative efficacy of classical cytostatics (doxorubicin, oxaliplatin, 5-fluorouracil). In addition, we also studied the possible interaction of sesquiterpenes with other drugs in combination therapy, which could be caused by sesquiterpene-mediated modulation of drug-metabolizing enzymes. For these purposes, a panel of various cell lines (both cancerous and non-cancerous) and primary culture of hepatocytes...
author2 Skálová, Lenka
author_facet Skálová, Lenka
Ambrož, Martin
author Ambrož, Martin
spellingShingle Ambrož, Martin
Seskviterpeny v protinádorové terapii
author_sort Ambrož, Martin
title Seskviterpeny v protinádorové terapii
title_short Seskviterpeny v protinádorové terapii
title_full Seskviterpeny v protinádorové terapii
title_fullStr Seskviterpeny v protinádorové terapii
title_full_unstemmed Seskviterpeny v protinádorové terapii
title_sort seskviterpeny v protinádorové terapii
publishDate 2017
url http://www.nusl.cz/ntk/nusl-370949
work_keys_str_mv AT ambrozmartin seskviterpenyvprotinadoroveterapii
AT ambrozmartin sesquiterpenesincancertherapy
_version_ 1718791710975197184